Jack Kotovsky News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jack kotovsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jack Kotovsky Today - Breaking & Trending Today
LLNL An analytical technique – known as Droplet™ Digital Polymerase Chain Reaction (ddPCR) – that was developed by LLNL scientists and engineers, has garnered an Impact Award from the Federal Laboratory Consortium. The technology has been commercialized by Bio-Rad Laboratories. Researchers from Lawrence Livermore National Laboratory (LLNL) and their colleagues who help them commercialize technologies have won three national technology transfer awards this year. The trio of awards, from the Federal Laboratory Consortium (FLC), represent the most national awards that LLNL has ever won in one year’s competition over the past 36 years. Two of the awards will be given for technologies to assist in the fight against COVID-19. One employs polymerase chain reaction (PCR) technology to diagnose the SARS-CoV-2 virus (the virus associated with COVID-19) and the other is a mechanical ventilator easily built from readily available parts to assist those suffering from Ac ....
The popular Lawrence Livermore National Laboratory s lecture series for middle and high school students, Science on Saturday, is going virtual this year with the theme âCombating COVID-19.â The free, online lectures, featuring leading LLNL researchers joined by Bay Area science teachers, are scheduled for 10 a.m., on four consecutive Saturdays, beginning Feb. 6. Each of the lectures will address a difference aspect of the scientific effort to combat the coronavirus. Feb. 6 - âMolecular Diagnostics in the Age of COVID: Designing a Portable Point-of-Care Device.â Presented by LLNL scientists Larry Dugan and Michael Triplett, joined by Tracy High School teacher Erin McKay, the lecture will provide an overview of how viruses infect a host leading to disease, the current state of the COVID-19 pandemic, the laboratoryâs previous work in molecular diagnostics, and efforts to develop a point-of-care device for use in a clinical setting. ....